Suchergebnisse - "restriction fragment length polymorphism SHM"

Combining MYD88 L265P mutation detection and clonality determination on CSF cellular and cell‐free DNA improves diagnosis of primary CNS lymphoma

Autoren: Bravetti, Clotilde Degaud, Michaël Armand, Marine et al.

Weitere Verfasser: Bravetti, Clotilde Degaud, Michaël Armand, Marine et al.

Quelle: British Journal of Haematology. 201:1088-1096

Schlagwörter: primary central nervous system lymphoma PCR, polymerase chain reaction, cytometric bead array, ddPCR, SHM, flow cytometry FR, polymerase chain reaction RFLP, cerebrospinal fluid ctDNA, digital droplet polymerase chain reaction DLBCL, diffuse large B-cell lymphoma FCM, LOC, framework regions IG, circulating tumor DNA ddPCR, cfDNA, restriction fragment length polymorphism, lymphomes oculo-cerebraux NGS, circulating tumor DNA, Gene Rearrangement, cell-free DNA CSF, FCM, CNS lymphoma, immunoglobulin IGH, 3. Good health, PCR, interleukins LOC, NGS, next-generation sequencing PCNSL, RFLP, CBA, Cell-Free Nucleic Acids, diffuse large B-cell lymphoma, CSF, restriction fragment length polymorphism SHM, [SDV.GEN.GH] Life Sciences [q-bio]/Genetics/Human genetics, cerebrospinal fluid, cell-free DNA, FR, lymphomes oculo-cerebraux, Humans, immunoglobulin heavy chain IL, digital droplet polymerase chain reaction, PCNSL, Retrospective Studies, IG, primary central nervous system lymphoma, flow cytometry, IGH, immunoglobulin heavy chain, IL, ctDNA, framework regions, interleukins, DLBCL, Myeloid Differentiation Factor 88, Mutation, somatic hypermutation clonality, next-generation sequencing, MYD88, immunoglobulin, cytometric bead array cfDNA

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/36941788